Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on C4 Therapeutics (CCCC) and Achieve Life Sciences (ACHV) with bullish sentiments.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
C4 Therapeutics (CCCC)
TD Cowen analyst Tyler Van Buren maintained a Buy rating on C4 Therapeutics today. The company’s shares closed last Tuesday at $3.10.
According to TipRanks.com, Buren is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for C4 Therapeutics with a $14.50 average price target.
See Insiders’ Hot Stocks on TipRanks >>
Achieve Life Sciences (ACHV)
In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Achieve Life Sciences, with a price target of $20.00. The company’s shares closed last Tuesday at $5.84.
According to TipRanks.com, Walsh is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Achieve Life Sciences with a $13.20 average price target, a 146.7% upside from current levels. In a report issued on May 7, TipRanks – Google also reiterated a Buy rating on the stock with a $5.50 price target.
Read More on CCCC:
